CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis.
Damiano MarastoniAnna I PisaniGianmarco SchiaviValentina MazziottiMarco CastellaroAgnese TamantiFrancesca BoselloFrancesco CrescenzoGiuseppe K RicciardiStefania MontemezziFrancesca B PizziniMassimiliano CalabresePublished in: Therapeutic advances in neurological disorders (2022)
CSF inflammatory markers may provide prognostic information in predicting disease activity in the first years after DMF initiation. CSF TNF levels are a possible candidate in predicting treatment response, in addition to clinical, demographic and MRI variables.